Dynamic Metabolic Reprogramming in Macrophages during Immune Response
免疫反应期间巨噬细胞的动态代谢重编程
基本信息
- 批准号:10540831
- 负责人:
- 金额:$ 23.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-09 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:Acetyl Coenzyme AAutoimmune DiseasesAutomobile DrivingBasic ScienceCellsCitric Acid CycleCommunicable DiseasesCoupledCouplingData SetDiseaseFailureFoundationsGene ExpressionGenesGoalsHealthHistone AcetylationHumanImmuneImmune ToleranceImmune responseImmunityInflammationInflammatoryInnate Immune SystemInterferon Type IIInterferonsInterventionInvestigationIsotopesKnowledgeLeadLipopolysaccharidesMediatingMetabolicMetabolic PathwayMetabolismModificationMolecularNitric OxideNucleotidesPathway interactionsPlayProcessPublishingPyruvate Dehydrogenase ComplexReactionRegulationResearchResolutionRoleSpecificityStatistical Data InterpretationStimulusStructureSystemTestingTimeTranscriptional RegulationWorkarmchronic inflammatory diseasefollow-upimmune functionmacrophagemultiple omicsnovelnucleotide metabolismpathogenpreferenceresponsetissue repair
项目摘要
Project Summary / Abstract
The overarching goal of this project is to understand how cellular metabolism is dynamically reprogrammed in
macrophages during immune responses, and how such metabolic reprogramming impacts immune functions.
Emerging research indicates that metabolism plays a crucial role in supporting and orchestrating immunity.
However, our understanding of macrophage metabolism is just beginning, and is largely limited to static
comparisons of metabolic preferences associated with different activation states. Understanding time-dependent
metabolic rewiring is of great significance because an immune response is a highly dynamic process, through
which macrophages undergo a sequence of functional transitions that mediate the onset and resolution of
inflammation. Proper regulation of macrophage responses is critical, as failure to activate or control macrophage
functions at the appropriate times can lead to a variety of diseases. The integrative approach that we take to
investigate dynamic metabolic rewiring during an immune response starts with a multi-omics characterization
that reveals metabolic processes whose alteration is temporally coupled to functional transitions. This is followed
by targeted perturbations to determine the impact of these metabolic alterations on immune functions. Then we
perform isotopic tracing studies to quantitatively characterize how fluxes through these pathways change during
immune responses and identify important regulatory points. Finally, in-depth molecular studies are used to
elucidate the mechanisms driving these key metabolic alterations and the mechanisms by which such metabolic
alterations orchestrate immune functions. Our preliminary work on the dynamic metabolic rewiring in
macrophages upon LPS and interferon-γ stimulation revealed that alterations in TCA cycle and nucleotide
metabolism are critical for this immune response. We discovered that metabolic fluxes through the TCA cycle
undergo a two-stage remodeling and that inhibition of the pyruvate dehydrogenase complex (PDHC) drives the
transition from early inflammatory stage to late suppressive stage. Building on this, aim 1 will investigate the
molecular mechanism causing PDHC inhibition, and test the hypothesis that PDHC inhibition drives the transition
into a more suppressive state and mediates immune tolerance by restricting acetyl-coA for histone acetylation.
Aim 2 will focus on nucleotide metabolism to quantitatively study how nucleotide synthesis, degradation, and
salvage fluxes change upon LPS and interferon-γ stimulation, and elucidate the mechanism driving such
changes. Aim 3 will expand the scope of this proposal by characterizing the dynamic metabolic reprograming in
response to a variety of other stimuli using multi-omics approaches. It will identify key metabolic transitions in
each response and create a roadmap towards mechanistic understanding of the metabolism-immunity coupling.
Overall, this proposal will elucidate the metabolic underpinnings of immune responses in macrophages, which
has great importance in basic science and broad relevance to diseases where macrophages play a key role.
项目总结/摘要
这个项目的首要目标是了解细胞代谢是如何动态地重新编程,
免疫应答过程中的巨噬细胞,以及这种代谢重编程如何影响免疫功能。
新兴的研究表明,新陈代谢在支持和协调免疫方面起着至关重要的作用。
然而,我们对巨噬细胞代谢的理解才刚刚开始,并且在很大程度上限于静态的
与不同激活状态相关的代谢偏好的比较。理解时间依赖性
代谢重新布线具有重要意义,因为免疫反应是一个高度动态的过程,通过
其中巨噬细胞经历一系列功能性转变,
炎症适当调节巨噬细胞反应至关重要,因为不能激活或控制巨噬细胞
功能在适当的时候可以导致各种疾病。我们采取的综合方法
研究免疫应答过程中动态代谢重新连接始于多组学表征
它揭示了代谢过程,这些代谢过程的改变在时间上与功能转变相关联。紧随其后的
通过有针对性的扰动来确定这些代谢改变对免疫功能的影响。然后我们
进行同位素示踪研究,以定量地描述这些途径的通量在
免疫反应和确定重要的调控点。最后,深入的分子研究被用来
阐明驱动这些关键代谢改变的机制以及这些代谢改变的机制,
改变协调免疫功能。我们对脑内动态代谢重组的初步研究
巨噬细胞在LPS和干扰素-γ刺激后显示TCA循环和核苷酸的改变,
代谢对于这种免疫反应至关重要。我们发现TCA循环中的代谢通量
经历两个阶段的重塑,并且丙酮酸脱氢酶复合物(PDHC)的抑制驱动
从早期炎症阶段过渡到晚期抑制阶段。在此基础上,aim 1将调查
分子机制引起的PDHC抑制,并测试的假设,PDHC抑制驱动转换
进入更抑制的状态,并通过限制乙酰辅酶A进行组蛋白乙酰化来介导免疫耐受。
目标2将集中在核苷酸代谢,定量研究核苷酸的合成,降解,
补救流量的变化后,LPS和干扰素-γ刺激,并阐明了驱动机制,
变化目标3将通过表征在细胞内的动态代谢重编程来扩展该提议的范围。
使用多组学方法对各种其他刺激的反应。它将确定关键的代谢转换,
每一个反应,并创建一个路线图对代谢免疫耦合的机制的理解。
总的来说,这项提议将阐明巨噬细胞免疫反应的代谢基础,
在基础科学中具有重要意义,并且与巨噬细胞发挥关键作用的疾病具有广泛的相关性。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A matter of time: temporal structure and functional relevance of macrophage metabolic rewiring.
- DOI:10.1016/j.tem.2022.02.005
- 发表时间:2022-05
- 期刊:
- 影响因子:10.9
- 作者:Seim, Gretchen L.;Fan, Jing
- 通讯作者:Fan, Jing
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jing Fan其他文献
Jing Fan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jing Fan', 18)}}的其他基金
Metabolic rewiring coupled to the production of reactive oxygen and nitrogen species (RONS)
代谢重新布线与活性氧和氮 (RONS) 的产生相结合
- 批准号:
10672344 - 财政年份:2022
- 资助金额:
$ 23.61万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 23.61万 - 项目类别:
Operating Grants
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 23.61万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 23.61万 - 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
- 批准号:
23K14742 - 财政年份:2023
- 资助金额:
$ 23.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
- 批准号:
10593224 - 财政年份:2023
- 资助金额:
$ 23.61万 - 项目类别:
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 23.61万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 23.61万 - 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
- 批准号:
23K06589 - 财政年份:2023
- 资助金额:
$ 23.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 23.61万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 23.61万 - 项目类别: